{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:15:45Z","timestamp":1788923745466,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) is a feared complication of inflammatory bowel disease (IBD). We aimed to investigate the prevalence and risk factors of CRC among a large cohort of IBD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data on IBD patients free of CRC at baseline was extracted using the MDClone platform of the Clalit health maintenance organization in Israel. We investigated the frequency rate of CRC among IBD patients compared to a control group without IBD. Possible risk factors, including comorbidities and IBD-related medications, were investigated in a multivariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a follow-up of 139,448\u2009years among Crohn\u2019s disease (CD) patients and 139,533\u2009years among ulcerative colitis (UC) patients, a frequency rate of CRC was 1.5% (191) among 12,888 CD patients and 2.1% (261) among 12,381 UC patients compared to 1.2% among 57,334 controls. In a multivariate analysis of UC patients, age at diagnosis (OR 1.030,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), primary sclerosing cholangitis (OR 2.487,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005), diabetes mellitus (OR 2.01,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), and glucocorticoids treatment (OR 1.465,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) were found to be predictors of CRC. For CD patients, age at diagnosis (OR 1.035,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), primary sclerosing cholangitis (OR 2.25,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029), and glucocorticoids treatment (OR 2.07,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) were found to be predictors for CRC, but not diabetes mellitus.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite the continuously decreasing rates of CRC among IBD patients, these are still higher in IBD patients compared to the general population. IBD patients, particularly those with risk factors, require special consideration in follow-up for CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2023.1225616","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T09:05:34Z","timestamp":1691399134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population"],"prefix":"10.3389","volume":"10","author":[{"given":"Naim","family":"Abu-Freha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bracha","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Weissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily H.","family":"Kestenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Vosko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abu-Tailakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Ben-Shoshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Shirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/bmj.1.5750.649","article-title":"Ulcerative colitis. Epidemiology and aetiology, course and prognosis","volume":"1","author":"De Dombal","year":"1971","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1055\/s-0037-1602237","article-title":"Colorectal cancer in inflammatory bowel disease","volume":"31","author":"Stidham","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.3748\/wjg.14.3937","article-title":"Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies","volume":"14","author":"Lakatos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"Rutter","year":"2006","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ibd.20036","article-title":"Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark","volume":"13","author":"Jess","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/01.MIB.0000160811.76729.d5","article-title":"Crohn\u2019s and colitis foundation of America colon cancer in IBD study group","volume":"11","author":"Itzkowitz","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1136\/gut.2003.038505","article-title":"Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk","volume":"53","author":"Rutter","year":"2004","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1053\/gast.2001.24052","article-title":"Family history as a risk factor for colorectal cancer in inflammatory bowel disease","volume":"120","author":"Askling","year":"2001","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO guidelines on inflammatory bowel disease and malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J Crohn\u2019s Colitis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4253\/wjge.v15.i3.133","article-title":"Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: what factors to consider?","volume":"15","author":"Gravina","year":"2023","journal-title":"World J Gastrointest Endosc"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2147\/CLEP.S151339","article-title":"Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study","volume":"10","author":"Friedman","year":"2018","journal-title":"Clin Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1747326","article-title":"Diabetes and colorectal cancer risk: clinical and therapeutic implications","volume":"2022","author":"Yu","year":"2022","journal-title":"J Diabetes Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"18456","DOI":"10.18632\/oncotarget.14472","article-title":"Diabetes cancer connect consortium. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41416-018-0314-4","article-title":"Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts","volume":"119","author":"Ma","year":"2018","journal-title":"Br J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","article-title":"Obesity and colorectal cancer","volume":"62","author":"Bardou","year":"2013","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1053\/j.gastro.2003.09.029","article-title":"Mortality in inflammatory bowel disease: a population-based cohort study","volume":"125","author":"Card","year":"2003","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12967-019-02164-3","article-title":"Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study","volume":"17","author":"Lin","year":"2019","journal-title":"J Transl Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","article-title":"Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases","volume":"7","author":"Ananthakrishnan","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1053\/j.gastro.2015.06.001","article-title":"Postoperative mortality among patients with inflammatory bowel diseases: a systematic review and meta-analysis of population-based studies","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/MEG.0000000000000891","article-title":"Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland","volume":"29","author":"B\u00e4hler","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.crohns.2014.02.015","article-title":"Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland","volume":"8","author":"Jussila","year":"2014","journal-title":"J Crohns Colitis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","article-title":"Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/apt.12115","article-title":"Use of systemic glucocorticoids and the risk of colorectal cancer","volume":"37","author":"Ostenfeld","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/apt.12286","article-title":"Letter: glucocorticoids use and the risk of colorectal cancer","volume":"37","author":"Lai","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4161\/onci.19459","article-title":"Colon cancer cells produce immunoregulatory glucocorticoids","volume":"1","author":"Sidler","year":"2012","journal-title":"Onco Targets Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e151815","DOI":"10.1172\/jci.insight.151815","article-title":"Intestinal epithelial glucocorticoid receptor promotes chronic inflammation-associated colorectal cancer","volume":"6","author":"Tang","year":"2021","journal-title":"JCI Insight"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.3748\/wjg.v21.i19.6026","article-title":"Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review","volume":"21","author":"Guraya","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/jnci\/dji375","article-title":"Diabetes mellitus and risk of colorectal cancer: a meta-analysis","volume":"97","author":"Larsson","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.dld.2022.08.017","article-title":"Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis","volume":"55","author":"Fuschillo","year":"2023","journal-title":"Dig Liver Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/ibd\/izaa252","article-title":"Lower rates of colorectal cancer in patients with inflammatory bowel disease using anti-TNF therapy","volume":"27","author":"Alkhayyat","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/ecco-jcc\/jjab184","article-title":"Impact of anti-tumour necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: Nationwide French cohort study","volume":"16","author":"Charkaoui","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"otab016","DOI":"10.1093\/crocol\/otab016","article-title":"Ethnicity influences risk of inflammatory bowel disease (IBD)-associated colon cancer: a cross-sectional analysis of dysplasia prevalence and risk factors in Hispanics and non-Hispanic whites with IBD","volume":"3","author":"Damas","year":"2021","journal-title":"Crohn\u2019s Colitis 360"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.21037\/jgo.2019.01.06","article-title":"Racial disparities in the incidence of colon cancer in patients with inflammatory bowel disease","volume":"10","author":"Vij","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/jpm13061008","article-title":"Ethnic issues and disparities in inflammatory bowel diseases: what can we learn from the Arab population in Israel?","volume":"13","author":"Abu-Freha","year":"2023","journal-title":"J Pers Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1225616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T10:04:30Z","timestamp":1691489070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1225616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":39,"alternative-id":["10.3389\/fmed.2023.1225616"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1225616","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"article-number":"1225616"}}